These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7255453)

  • 1. Antiarrhythmic structure activity relationships in a series of lidocaine procainamide derivatives.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1981; 24():221-4. PubMed ID: 7255453
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium.
    Courtney KR
    J Mol Cell Cardiol; 1980 Nov; 12(11):1273-86. PubMed ID: 6777501
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic drug action: selective depression of hypoxic cardiac cells.
    Hondeghem LM; Grant AO; Jensen RA
    Am Heart J; 1974 May; 87(5):602-5. PubMed ID: 4818704
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural simularities and cardiac electrophysiological differences between lidocaine and procainamide.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1980; 23():163-6. PubMed ID: 7403120
    [No Abstract]   [Full Text] [Related]  

  • 6. The comparative inotropic effects of six clinically used antiarrhythmic agents.
    Hammermeister KE; Boerth RC; Warbasse JR
    Am Heart J; 1972 Nov; 84(5):643-52. PubMed ID: 4639738
    [No Abstract]   [Full Text] [Related]  

  • 7. The electrophysiological actions of lidocaine on ischemic ventricular muscle as compared with procainamide.
    Toyama J; Furuta T
    Jpn Circ J; 1983 Jan; 47(1):82-91. PubMed ID: 6827774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticholinergic effect of procainamide and its sulfonylcarbamide derivatives on electromechanical activity in guinea pig atrium].
    Gurskaite H; Gendviliene V; Zablockaite D; Martisiene I; Stankevicius A
    Medicina (Kaunas); 2005; 41(12):1054-60. PubMed ID: 16401963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic and electrophysiological effects of CH-200.
    Hashimoto K; Tsukada T; Matsuda H; Imai S
    Eur J Pharmacol; 1977 Sep; 45(2):185-94. PubMed ID: 902689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of N-phenylmaleimides. Kinetics of the antifibrillatory action of a derivative of procainamide].
    Luu-Duc C; Marsura A; Charlon C; Merle D; Mazin D
    Farmaco Sci; 1985 Apr; 40(4):253-8. PubMed ID: 4018251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
    Phillips GB; Morgan TK; Nickisch K; Lind JM; Gomez RP; Wohl RA; Argentieri TM; Sullivan ME
    J Med Chem; 1990 Feb; 33(2):627-33. PubMed ID: 2299628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of substituted 2-aminopyrrole analogs of lidocaine II.
    Johnson RW; Keenan TH; Kosh JW; Sowell JW
    J Pharm Sci; 1979 Aug; 68(8):955-8. PubMed ID: 480174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antiarrhythmic agents. II. Antiarrhythmic activity of basic N-(substituted phenyl and benzyl)dipeptides.
    Lindberg UH; Akerman B
    Acta Pharm Suec; 1985; 22(6):321-34. PubMed ID: 3832783
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel quinolizidinyl derivatives as antiarrhythmic agents.
    Vazzana I; Budriesi R; Terranova E; Ioan P; Ugenti MP; Tasso B; Chiarini A; Sparatore F
    J Med Chem; 2007 Jan; 50(2):334-43. PubMed ID: 17228875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of lidocaine, propranolol, procaine amide, and bretylium tosylate on the contractility of isolated cat papillary muscles.
    Graham JD; Chandler BM
    Can J Physiol Pharmacol; 1973 Oct; 51(10):763-73. PubMed ID: 4753289
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antidysrhythmic effects of procainamide derivatives].
    Guerin ML; Morin H
    Therapie; 1977; 32(4):501-15. PubMed ID: 605427
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of procaine on the passive electrical properties of guinea-pig ventricular muscle.
    Ochi R; Hashimoto K
    Pflugers Arch; 1978 Dec; 378(1):1-7. PubMed ID: 569820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new series of antiarrhythmic procainamide derivatives: toxicity and activity-simulated passive absorption relation.
    Brazier M; Lefebvre C; Robert H; Reynaud P; Nguyen-Tri-Xuong E; Arnould-Guérin ML; Pieri F
    Farmaco; 1990 Dec; 45(12):1351-9. PubMed ID: 2090144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.
    Osadchii OE
    Fundam Clin Pharmacol; 2014 Aug; 28(4):382-93. PubMed ID: 23952942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of quinetholate, lidocaine and procainamide on ouabain-induced ventricular tachycardia and cardiac function.
    Taylor SE; Nash CB
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):279-90. PubMed ID: 677962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.